Numinus to Participate in the Cantor Neurology & Psychiatry Conference on October 6-7, 2022
Numinus Wellness Inc. (TSX: NUMI, OTCQX: NUMIF), a leader in mental health care, will participate in the Cantor Neurology & Psychiatry Conference on October 6-7, 2022, in San Francisco.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Numinus Wellness Inc. (TSX: NUMI, OTCQX: NUMIF), a leader in mental health care, will participate in the Cantor Neurology & Psychiatry Conference on October 6-7, 2022, in San Francisco. Founder and CEO Payton Nyquvest will feature in the Digital-Pharma and a New Way of Thinking for NeuroPsych panel on October 7 at 9:00 a.m. PT. Numinus will also partake in a virtual fireside chat during the Cantor Symposium on Mental Health Clinics on October 11, 2022, at 11:00 a.m. ET. The company focuses on innovative, evidence-based psychedelic-assisted therapies aimed at mental health improvement.
Details
News Market Reaction – NUMIF
The recorded move for NUMIF in the trading session of this news was -2.85%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
VANCOUVER, BC, Sept. 29, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in the Cantor Neurology & Psychiatry Conference to be held at The Ritz-Carlton in San Francisco on October 6-7, 2022.
Payton Nyquvest, Founder and CEO of Numinus, will participate in the Digital-Pharma and a New Way of Thinking for NeuroPsych panel on Friday, October 7th at 9:00 a.m. PT.
In addition, Numinus will participate in the Cantor Symposium on Mental Health Clinics on Tuesday, October 11, 2022. Mr. Nyquvest will participate in a virtual fireside chat with Pablo Zuanic, Cantor Research Analyst, at 11:00 a.m. ET / 8:00 a.m. PT. To attend, please register here:
https://us06web.zoom.us/webinar/register/WN_j0ChDwu_Tn6EFJfMUYjfqA
For more information about the conference, or to schedule a one-on-one meeting with Numinus' management, please contact your appropriate Cantor representative directly, or send an email to KCSA Strategic Communications NuminusIR@kcsa.com.
About Numinus
Numinus Wellness (TSX: NUMI) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model - including psychedelic production, research and clinic care - is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Learn more at www.numinus.com and follow us on LinkedIn, Facebook, Twitter, and Instagram.
Forward-looking statements
Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect" and "intend" and statements that an event "may", "will", "should", "could" or "might" occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. The Company does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.
View original content:https://www.prnewswire.com/news-releases/numinus-to-participate-in-the-cantor-neurology--psychiatry-conference-on-october-6-7-2022-301637068.html
SOURCE Numinus Wellness Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.